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Abstract
 
According to a recently proposed hypothesis, initiation of signal transduction via immunorecep-
tors depends on interactions of the engaged immunoreceptor with glycosphingolipid-enriched
membrane microdomains (GEMs). In this study, we describe a novel GEM-associated trans-
membrane adaptor protein, termed phosphoprotein associated with GEMs (PAG). PAG com-
prises a short extracellular domain of 16 amino acids and a 397-amino acid cytoplasmic tail con-
taining ten tyrosine residues that are likely phosphorylated by Src family kinases. In lymphoid
cell lines and in resting peripheral blood 
 
a
 
/
 
b
 
 T cells, PAG is expressed as a constitutively ty-
rosine-phosphorylated protein and binds the major negative regulator of Src kinases, the ty-
rosine kinase Csk. After activation of peripheral blood 
 
a
 
/
 
b
 
 T cells, PAG becomes rapidly de-
phosphorylated and dissociates from Csk. Expression of PAG in COS cells results in recruitment
of endogenous Csk, altered Src kinase activity, and impaired phosphorylation of Src-specific
 
substrates. Moreover, overexpression of PAG in Jurkat cells downregulates T cell receptor–
mediated activation of the transcription factor nuclear factor of activated T cells. These findings
collectively suggest that in the absence of external stimuli, the PAG–Csk complex transmits
negative regulatory signals and thus may help to keep resting T cells in a quiescent state.
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Introduction
 
Signal transduction by immunoreceptors (TCRs, B cell re-
ceptors, and most Fc receptors) after their aggregation by
natural ligands or Abs is initiated by activation of protein
tyrosine kinases (PTKs)
 
1
 
 of the Src and Syk families, which
phosphorylate a variety of substrates, thus allowing propa-
gation of the initial stimulus to cytosolic signaling pathways
(1). Other structural membrane elements apparently impor-
tant for initiation of immunoreceptor-mediated signaling
are the so-called glycosphingolipid-enriched microdomains
 
1
 
Abbreviations used in this paper:
 
 aa, amino acid(s); EST, expressed sequence
tag; GEM, glycosphingolipid-enriched microdomain; GST, glutathione
 
S
 
-transferase; ITAM, immunoreceptor tyrosine-based activation motif;
LAT, linker for activation of T cells; Nano ES MS/MS, nanoelectrospray
tandem mass spectrometry; NF-AT, nuclear factor of activated T cells;
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(GEMs), also known as membrane rafts or detergent-insol-
uble glycolipid-rich membrane domains (2, 3). These are
small islets (
 
,
 
70 nm) in the plasma membrane of most cell
types and are enriched in glycosphingolipids, sphingomy-
elin, and cholesterol. The major extracellular protein com-
ponents of GEMs are molecules that are anchored in the
outer membrane leaflet via a glycolipid (glycosylphosphati-
dylinositol) anchor. In contrast, most transmembrane pro-
teins (with a few exceptions) are excluded from the GEMs
(4, 5). GEMs seem to form a specific “ordered liquid phase”
more or less separated from the less-ordered bulk mem-
brane, presumably because of their high content of choles-
terol and lipids possessing saturated acyl chains (6, 7). GEMs
are relatively resistant to solubilization at 0–4
 
8
 
C by some
types of detergents (e.g., Triton X-100, NP-40, Brij series),
but are mostly dissociated by detergents of the 
 
n
 
-alkyl gly-
cosidic type (octylglucoside, dodecylmaltoside [8-10]). Be-
cause of their high lipid content, GEMs can be conve-
niently isolated from detergent extracts by density gradient
ultracentrifugation (8). The cytoplasmic side of GEMs is
associated with several molecules involved in initiation of
immunoreceptor signaling (11–17). These are heterotrim-
eric G proteins, Src family kinases, and the recently cloned
transmembrane adaptor protein linker for activation of T
cells (LAT). Src family kinases and G proteins are anchored
in the plasma membrane by means of NH
 
2
 
-terminal dual
acylation with long saturated fatty acids (16, 17). Similarly,
the transmembrane protein LAT is targeted to GEMs of T
lymphocytes by palmitoylation of two membrane-proximal
cysteine residues (15). At least a fraction of the CD4 and
CD8 co-receptors is also found in GEMs (18), possibly be-
cause of their association with Lck and/or LAT (19, 20).
Initiation of immunoreceptor signaling is accompanied
by association of the receptor components with GEMs
(21–27). Furthermore, treatments disrupting GEMs (cho-
lesterol depletion, biosynthetic partial replacement of their
saturated fatty acids by polyunsaturated ones) inhibits im-
munoreceptor signaling (22, 28, 29). A plausible hypothesis
explaining the requirement of GEMs for immunoreceptor
signaling is that immunoreceptor complexes merge with
GEMs upon interaction (aggregation) with their ligands,
and thus their immunoreceptor tyrosine-based activation
motif (ITAM)-bearing chains become exposed to Src fam-
ily kinases concentrated in GEMs. Furthermore, at least in
T cells, a major substrate of the ZAP70 PTK, the linker
protein LAT, is also present in these “signaling islets” (14,
15). Therefore, GEMs may well act as preformed “signalo-
somes” for initiation and spatial organization of early phases
of immunoreceptor signaling.
One as yet unidentified component of the GEMs is an
80-kD phosphoprotein that was repeatedly observed as a
major constituent of in vitro–labeled immunoprecipitates
prepared from various types of GEMs (9, 10, 30, 31). Simi-
larly, we have demonstrated previously that an unknown
highly acidic 80–85-kD phosphoprotein is a component of
an oligomeric protein complex that is formed in resting pe-
ripheral blood lymphocytes between the Src family PTK
Fyn and several phosphoproteins (32–34). In this report,
 
we describe molecular cloning and preliminary functional
characterization of this GEM/Fyn-associated pp80 polypep-
tide, which we termed phosphoprotein associated with
GEMs (PAG).
 
Materials and Methods
 
Cells. 
 
a
 
/
 
b
 
 T cells (99.5% pure, 
 
.
 
85% propidium iodide neg-
ative) were prepared from buffy coats by Ficoll centrifugation and
preparative cell sorting using a FACS Vantage™ flow cytometer
(Becton Dickinson) to remove monocytes, B, NK, and 
 
g
 
/
 
d
 
 T cells.
Sorted cells were allowed to rest for at least 24 h in RPMI 1640
medium (GIBCO BRL) supplemented with 10% human AB se-
rum. P116 cells (a gift from Dr. R. Abraham, The Mayo Clinic,
Rochester, NY; reference 35), J.CaM1.6 cells (donated by Dr. A.
Weiss, University of California at San Francisco, San Francisco,
CA; reference 36), and the other cell lines used were maintained
in medium supplemented with 10% FCS, 1% penicillin-strepto-
mycin, and 2% glutamine (all supplements from GIBCO BRL).
 
Purification of pp80.
 
7 
 
3
 
 10
 
8
 
 Raji cells were lysed in 6 ml of
1% NP-40 lysis buffer A (20 mM Tris-HCl, pH 8.2, 140 mM
NaCl, 1% NP-40 [Fluka], 5 mM iodoacetamide, 1 mM Pefabloc
[4-(2-aminoethyl)-benzensulfonyl fluoride; Sigma-Aldrich]) on
ice for 30 min, then mixed 1:1 with ice-cold 80% (wt/vol) su-
crose diluted in lysis buffer A. Six 5-ml ultracentrifugation tubes
were filled with 2 ml of this suspension, followed with ice-cold
2.5 ml of 30% sucrose and finally 0.5 ml of sucrose-free lysis
buffer A. These tubes were centrifuged at 52,000 rpm in a SW55
swing-out rotor (cca 250,000 
 
g
 
; Beckman Coulter) for 18 h at
4
 
8
 
C. 0.7-ml fractions were collected near the top, pooled, mixed
with 6.3 ml of acetone, precipitated overnight at 
 
2
 
20
 
8
 
C, and
sedimented by a 15-min centrifugation at 15,000 
 
g
 
 at 0
 
8
 
C. The
air-dried pellet was resuspended in 50 
 
m
 
l of 20 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 1% Triton X-100 (Sigma-Aldrich),
briefly sonicated, and then subjected to two-dimensional gel elec-
trophoresis (37). The wet gel was silver stained, and the spot cor-
responding to PAG (as judged from a parallel phosphotyrosine
blot) was excised and subjected to sequencing.
 
Precipitation Experiments. 
 
Immunoprecipitations were per-
formed as described previously (38) using postnuclear superna-
tants of 1% detergent (Triton X-100, NP-40, or laurylmaltoside
[n-dodecyl 
 
b
 
-D-maltoside; Sigma-Aldrich]) cell lysates (lysis
buffer: Tris-buffered saline, pH 7.5, containing 1 mM Pefabloc,
10 mM EDTA, 10 mM NaF, 1 mM NaVO
 
3
 
) and CNBr
Sepharose beads (Amersham Pharmacia Biotech) coupled with
Protein A–purified mAbs. Precipitations using recombinant glu-
tathione 
 
S
 
-transferase (GST)-coupled Src homology (SH)2 do-
mains were performed as described elsewhere (32, 38). The SH2
domains of Csk, Vav, and Ras-GAP were provided by Dr. A.
Beyers (University of Stellenbosch Medical School, Tygerberg,
South Africa). All other SH2 domains have been described else-
where (32, 38). Precipitates were washed and then either sub-
jected to SDS-PAGE or further processed for two-dimensional
gel electrophoresis, in vitro kinase assay, or reprecipitation exper-
iments. GEMs were immunoprecipitated from Raji and Jurkat
cells by the “solid phase immunoisolation technique” followed by
in vitro kinase assays, as described previously (9). Reprecipitation
experiments were conducted as described elsewhere (37, 38). In
some experiments, immunoisolation was performed using mini-
columns (25–200-
 
m
 
l packed volume) of CNBr Sepharose beads
coupled with Protein A–purified mAbs. Postnuclear lysates were
passed through the columns. After washing with 10-column vol- 
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umes of lysis buffer, bound proteins were eluted with 2-column
volumes of 2% SDS and the flow-through, and eluted fractions
were analyzed by SDS-PAGE followed by Western blotting.
 
In Vitro Kinase Reaction, Two-dimensional Gel Electrophoresis,
Density Gradient Ultracentrifugation, and Western Blotting. 
 
In vitro
kinase reaction, two-dimensional gel electrophoresis, and West-
ern blot analysis were performed essentially as described previ-
ously (37), with the exception of the experiment shown in Fig. 8
B, where 1 
 
m
 
M cold ATP was added to the kinase buffer. For re-
producible detection of GEM components (such as PAG) by
Western blotting, it was necessary to solubilize the cells by 1%
laurylmaltoside to avoid losses during removal of nuclei by low-
speed
 
 
 
centrifugation. Density gradient ultracentrifugation was per-
formed essentially as described above, except that standard lysis
buffer with 1% detergents (Brij58, laurylmaltoside) was used, sam-
ple size (in 40% sucrose) was 1 ml, and the 30% sucrose layer was
3.5 ml. After ultracentrifugation, the gradient was separated into
eight fractions of equal volume. These and the sediment were fur-
ther analyzed by SDS-PAGE and Western blotting.
 
Peptide Sequencing. 
 
The protein spot corresponding to pp80
was excised from the silver-stained two-dimensional gel and in-
gel digested with trypsin as described (39). Tryptic peptides were
extracted from the gel matrix by 5% formic acid and acetonitrile,
and extracts were pooled and dried. The sample was redissolved
in 5% formic acid and analyzed by nanoelectrospray tandem mass
spectrometry (Nano ES MS/MS) as described (40). Analyses were
performed on a triple quadrupole mass spectrometer (API III; PE
Sciex Instruments) equipped with the nanoelectrospray ion source
developed at European Molecular Biology Laboratory (EMBL
[41]). Acquired tandem mass spectra were interpreted manually
using AppleScript-based software developed at EMBL. Searching
against comprehensive protein and expressed sequence tag (EST)
sequence databases was performed by PeptideSearch v3.0 software
developed at EMBL.
 
cDNA Cloning. 
 
Based on an EST cDNA sequence AA220201
corresponding to the FSSLSYK peptide obtained by Nano ES
MS/MS sequencing of purified pp80, forward and nested for-
ward oligonucleotides (TTGTCATACAAGTCTCGGGAAGAA-
GACC and GGACAGTTAGTGAATAAATCGGGGCAG) and
reverse and nested reverse oligonucleotides (CTGCGGGTG-
AAAGTGTGCTGTTTGGAG and AGGAGGAGGGTG AC-
CTCTGTGGGTCC) were used as primers for 3
 
9
 
- and 5
 
9
 
-rapid
amplification of cDNA end (RACE) reaction performed on Leu-
cocyte Marathon-ready™ cDNA (CLONTECH Laboratories,
Inc.) using the Advantage
 
®
 
 cDNA PCR kit (CLONTECH Labo-
ratories, Inc.) according to the manufacturer’s instructions. The
RACE products were sequenced yielding the entire sequence of
the 3
 
9
 
 end of the coding region, whereas the 5
 
9
 
 part of the coding
region was still incomplete, and another round of 5
 
9
 
 RACE had
to be performed with ATP-tailed Raji cDNA. The cDNA en-
coding mouse homologue of PAG was cloned by a similar ap-
proach based on knowledge of mouse EST sequences covering
the 5
 
9
 
 and 3
 
9
 
 regions of the gene.
 
cDNA Constructs, Transfection. 
 
The coding region of human
wild-type PAG and Csk was amplified from Jurkat cDNA (primers:
CCCTCGGCTGGTGCCAGTGC versus GCAGCATATGAA-
GTATAGGTTTGTG for PAG and CTGAGAAGATGTCAGC-
AATACAGGCC versus GAGGCCAGCCGTCACAGGTGCAG
for Csk). The PCR products were cloned into the BstXI site of the
eukaryotic expression vector pEF-BOS (42). The FLAG-PAG
construct encoding the full-length PAG containing the COOH-
terminal FLAG and the various PAG mutants carrying tyrosine to
phenylalanine exchanges were produced by site-directed muta-
genesis using the QuikChange™ site-directed mutagenesis kit
(Stratagene) according to the manufacturer’s instructions.
Transient transfection of Jurkat and COS cells was performed
essentially as described (38). For the transfection experiments in
COS cells, we used the following cDNA constructs: wild-type
Fyn cloned in pSR
 
a
 
 expression vector (provided by Dr. A. da
Silva, Dana Farber Cancer Institute, Boston, MA), MYC-tagged
Lck or ZAP70 inserted into pcDNA3 vector (donated by Dr. R.
Abraham), FLAG-tagged Syk cloned into the p5C7 vector (pro-
vided by Dr. W. Kolanus, Gene Center, Munich, Germany), and
FLAG-tagged SH2 domain–containing leukocyte phosphopro-
tein (SLP)-76 cDNA construct in pEF-BOS (a gift of Dr. G. Ko-
retzky, University of Pennsylvania, Philadelphia, PA). The cDNA
construct coding for a chimeric 
 
z
 
 molecule (consisting of the ex-
tracellular domain of CD25 [Tac] fused to the transmembrane
and cytoplasmic domain of the TCR 
 
z
 
 chain) was provided by
Dr. A. Veillette (McGill University, Montreal, Quebec, Canada).
For bacterial expression, the PAG intracellular fragment corre-
sponding to amino acid (aa) residues 97–432 was cloned to BamHI
site of pET-15b expression vector (Novagen), generating a con-
struct with NH
 
2
 
-terminal His tag.
 
Northern Blots. 
 
Human multiple-tissue Northern blots and
multiple-tissue expression arrays were obtained from CLON-
TECH Laboratories, Inc. and hybridized as described previously
(38) with a PAG-specific cDNA probe encompassing nucleotides
257–1685, i.e., corresponding to a full coding region and an addi-
tional 132 residues of the untranslated sequences.
 
Abs. 
 
The following mAbs were used (if not stated other-
wise, the mAbs are products of the authors’ laboratories): CD59
(MEM-43), CD18 (MEM-48), CD25 (AICD25.1), T cell recep-
tor–interacting molecule (TRIM)-01, phosphotyrosine (P-Tyr)–
01 and 4G10, conjugated with horseradish peroxidase (Upstate
Biotechnology), FLAG (M2; Eastman Kodak Co.), MYC (9E10,
a gift from Dr. D. Cantrell, Imperial Cancer Research Fund,
London, UK), rabbit antisera to Lck and Fyn (provided by Dr. A.
Veillette), rabbit antiserum to LAT (provided by Dr. L. Samelson,
National Institute of Child Health and Human Development,
NIH, Bethesda, MD; reference 13), Csk and G-proteins 
 
b
 
 sub-
units (rabbit Abs from Santa Cruz Biotechnology, Inc.), mitogen-
activated protein kinase (rabbit antiserum from Upstate Biotech-
nology). Horseradish peroxidase–conjugated polyclonal Abs to
mouse and rabbit Ig were from Bio-Rad or Dianova.
To raise mouse polyclonal and mAbs to the intracellular do-
main of PAG, F
 
1
 
(BALB/c 
 
3
 
 B10.A)
 
 
 
hybrid mice were immu-
nized with the bacterially expressed His-tagged PAG fragment
described above. Hybridomas were prepared and selected by stan-
dard techniques using Sp2/0 myeloma cells as fusion partners.
 
Biosynthetic Labeling with [
 
3
 
H]Palmitate. 
 
5 
 
3
 
 10
 
7
 
 Jurkat or
Raji cells were starved for 1 h at 37
 
8
 
C in 50 ml of plain RPMI
1640 medium. Then, 2.5-mCi radiolabeled palmitate ([9,10(
 
n
 
)-
 
3
 
H]palmitic acid, specific activity 40–60 Ci/mmol; Amersham
Pharmacia Biotech) in 100 
 
m
 
l ethanol and 10% extensively dia-
lyzed FCS (against PBS) was added. After 3 h at 37
 
8
 
C, the cells
were washed and solubilized in a 1% laurylmaltoside lysis buffer,
and the postnuclear supernatant was used for immunoprecipita-
tion followed by SDS-PAGE. The wet gel was treated with Am-
plify solution (Amersham Pharmacia Biotech) according to the
manufacturer’s recommendation, dried, and subjected to fluorog-
raphy for 3 wk.
 
Cytofluorometry of Permeabilized Blood Cells and Confocal Laser-
scan Microscopy. 
 
After 10 min of blocking of Fc receptors by
20% human AB serum, cells were permeabilized with 20 
 
m
 
g/ml
digitonin and stained using the first-step mAbs followed by fluo- 
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rescein goat anti–mouse IgG. Samples were measured on a FAC-
Sort™ flow cytometer (Becton Dickinson) in a standard three-
color setup. Leukocyte populations were resolved on the basis of
their scatter properties. The subcellular localization of PAG in
Raji cells was determined by confocal laser scan microscopy as
described elsewhere (38), using PAG mAb MEM-250 (10 
 
m
 
g/ml,
diluted in PBS/BSA) and Cy2 donkey anti–mouse IgG (Di-
anova). Nuclei were stained with propidium iodide (0.1 
 
m
 
g/ml).
Cells were analyzed on a Laserscan microscope (Ernst Leitz
GmbH) using 570 nm (red emission) and 508 nm (green emis-
sion) filters, respectively.
 
Cell Activation and Luciferase Reporter Gene Assay. 
 
In vitro ac-
tivation of T cells was performed using IgM anti-CD3 mAb
MEM-92 at 50 
 
m
 
g/ml or culture supernatants of anti-TCR mAb
C305 (IgM; a gift from Dr. A. Weiss) and anti-CD28 mAb (IgM;
donated by Dr. U. Moebius, University of Heidelberg, Heidel-
berg, Germany) or pervanadate as described previously (38, 43,
44). The Src family kinase–specific inhibitor PP1 (Calbiochem;
provided by Dr. P. Dráber, Institute of Molecular Genetics,
Prague, Czech Republic; reference 45) was used at 10 
 
m
 
g/ml.
Luciferase assays were performed essentially as described previ-
ously (45), with the exception that in addition to the cDNA con-
structs coding for Fyn, FLAG-tagged SLP-76 (15 
 
m
 
g each) and
the nuclear factor of activated T cells (NF-AT)–driven luciferase
reporter gene (5 
 
m
 
g) cells were transfected with 1 
 
m
 
g of a reporter
gene coding for Renilla luciferase (whose activity is independent
of the activation status of the cells). Luciferase activity was deter-
mined using the Dual-Luciferase
 
®
 
 assay kit from Promega. Nor-
malized luciferase units were determined by the following calcu-
lation: (NF-AT luciferase units/Renilla luciferase units) 
 
3
 
 10
 
5
 
.
 
Results
 
Purification and cDNA Cloning of PAG. 
 
In vitro kinase
assays performed on GEMs immunoprecipitated by, for ex-
ample, CD59 mAb from leukocytes typically produce two
major species of phosphorylated proteins: one with a molec-
ular mass of 55–60 kD (previously identified as Src family ki-
nases) and the other, as yet unidentified, with a molecular
mass of 
 
z
 
80 kD (Fig. 1 A). Moreover, an acidic 85-kD
phosphoprotein is a component of the recently described
Fyn complex (33) and can be visualized after two-dimen-
sional gel electrophoresis of an in vitro–labeled Fyn immu-
noprecipitate prepared from resting human T cells (Fig.
1 B). Finally, a constitutive tyrosine-phosphorylated 70–80-
kD protein is expressed in peripheral blood leukocytes and
lymphoid cell lines and associates with GEMs, as defined by
flotation in density gradients (Fig. 1 C). We suspected that
these 80–85-kD GEM- and Fyn-associated phosphopro-
teins as well as the prominent pp70–80 found in leukocytes
might represent the same molecule, and thus attempted its
characterization.
Since the expression of GEM-associated pp80 was found
to be highest in the B cell line Raji, GEMs were isolated
from 7 
 
3 
 
10
 
8
 
 Raji cells and subjected to two-dimensional
gel electrophoresis. An acidic spot of 75–85 kD was de-
tected by silver staining (Fig. 2 A) and verified by antiphos-
photyrosine staining of a corresponding blot (not shown).
This spot was excised and digested in-gel with trypsin, and
resulting peptides were sequenced by Nano ES MS/MS
(Fig. 2 B). Database searching hit two peptides encoded
by the EST clones AA960867, AA622656 (LLDENEN-
LQEK), and AA220201 (FSSLSYK), respectively. Reverse
and forward primers deduced from EST clone AA220201
were used for 5
 
9 and 39 RACE experiments to amplify the
rest of the corresponding gene from human leukocyte
cDNA. The sequence corresponding to the very 59 end of
the gene was finally obtained by 59 RACE performed on
cDNA obtained from Raji RNA.
An open reading frame of 1,296 nucleotides (not shown)
codes for a polypeptide of 432 aa and a predicted molecular
weight of 46,980; finally, four peptides sequenced by Nano
ES MS/MS were matched to the full-length sequence of
the protein (Fig. 2 C). Because of the fact that the phos-
phoprotein was purified from GEMs, we termed it phos-
phoprotein associated with GEMs. In Jurkat T cells tran-
siently transfected with an expression vector encoding
PAG, a 68-kD polypeptide (see below) was detected by an
anti-PAG mAb that exactly comigrated with the endoge-
nously expressed protein (Fig. 2 D). This indicates that the
sequenced cDNA contains the complete PAG gene.
Figure 1. pp80 accumulates in GEMs and associates with Fyn in peripheral blood T cells. (A) GEMs immunoprecipitated from NP-40 lysates of Raji
and Jurkat cells by anti-CD59 or control (Ctr) mAb were subjected to in vitro kinase assay followed by SDS-PAGE and autoradiography. (B) A Fyn im-
munoprecipitate obtained from peripheral blood T cells was subjected to in vitro phosphorylation and two-dimensional electrophoresis; the previously
identified and so far unidentified components (p43 and p85) are indicated. (C) Jurkat cells were solubilized in a 1% NP-40 lysis buffer, the suspension was
subjected to sucrose gradient ultracentrifugation, and the fractions (numbered 1–8 from top to bottom) were analyzed by SDS-PAGE followed by anti–
P-Tyr Western blotting.1595 Brdi ka et al. c ˘
To assess whether PAG is identical to the GEM- and
Fyn-associated pp80 and to the major leukocyte tyrosine-
phosphorylated 80-kD polypeptide, GEMs were immuno-
precipitated from Raji cells using CD59 mAb and sub-
jected to in vitro kinase assay followed by reprecipitation
using anti-PAG mAbs. As demonstrated in Fig. 3 A, pp80
was selectively reprecipitated from the mixture of in vitro–
phosphorylated GEM proteins. Similarly, a polyclonal
mouse anti-PAG Ab reprecipitated pp80–85 from an in
vitro–labeled Fyn immunoprecipitate prepared from resting
human T lymphocytes (Fig. 3 B). Finally, anti-PAG immu-
nosorbent specifically removed the tyrosine-phosphory-
lated 75–80-kD protein from lysates of peripheral blood T
cells (Fig. 3 C). Thus, PAG is identical to GEM/Fyn-asso-
ciated pp80–85 and to the leukocyte tyrosine-phosphory-
lated pp80.
Molecular Characterization of PAG.  The first methio-
nine of PAG is not followed by any typical signal sequence
Figure 2. Purification and
cDNA cloning of PAG. (A)
GEMs prepared from 7 3 108
Raji cells were separated by
two-dimensional electrophore-
sis followed by silver staining of
the gel. The arrow indicates the
position of pp80, which was
verified by anti–P-Tyr Western
blotting (not shown). The silver-
stained spot was excised and sub-
jected to Nano ES MS/MS. (B)
Sequencing of the p85 protein
by Nano ES MS/MS. Top: a
part of the spectrum of in-gel
tryptic digest of the p85 protein.
The peptide ions designated
with  * are autolysis products of trypsin. Ions of tryptic peptides originating from the p85 protein are designated with T. These ions were in turn isolated
by the quadrupole mass filter of a triple quadrupole tandem mass spectrometer and fragmented in the collision cell, and their tandem mass spectra were
acquired. The tandem mass spectrum acquired from the doubly charged peptide precursor ion having m/z 673.0 is shown (bottom). A short stretch of
the peptide sequence was determined by considering precise mass differences between the adjacent fragment ions containing the COOH terminus (y-ions;
reference 62). Note that the NH2-terminal aa of the peptide is at the right-hand side. The peptide sequence tag (reference 63) was assembled using the
deduced peptide sequence, masses of the correspondent fragment ions, and the mass of the intact peptide, and was used for searching comprehensive
protein and EST databases. Searching against a protein sequence database produced no hit. Searching against an EST database hit the peptide sequence
LLDENENLQEK that is present in the clone AA622656 and in several homologous clones. The match was verified by comparing the masses of frag-
ment ions calculated for the retrieved peptide sequence and the masses of peptide ions observed in the tandem mass spectrum. The COOH-terminal
part of the peptide sequence is covered by continuous series of y-ions (in bold), and the NH2-terminal part of the sequence is covered by series of b-ions
(reference 62). Thus database searching provided confident identification, although only a single peptide matched the sequence of the EST clone. Simi-
larly, tandem mass spectrum acquired from the precursor ion with m/z 416.2 hit the peptide sequence FSSLSYK present in the EST clone AA220201
(data not shown). After a full-length sequence of the protein was obtained from the cDNA nucleotide sequence, more tandem mass spectra were retro-
spectively matched to correspondent tryptic peptides: T1, IPPESAVDTMLTAR; T4, ELPGPQTEGK. A stretch of the peptide sequence similar to the
sequence of T1 (...PPESAVD...) was deduced from tandem mass spectra acquired from peptide ions T2 and T3. (C) aa sequence of human (upper) and
mouse (lower) PAG. The putative transmembrane region is boxed. All tyrosines are in bold, and the putative tyrosine-based signaling motifs are over-
lined in bold. The peptides sequenced by Nano ES MS/MS are indicated by a thin line over the corresponding sequences. These sequence data are
available from EMBL/GenBank/DDBJ under accession nos. AF240634 (human) and A5250192 (mouse). (D) Jurkat cells were transfected with cDNA
encoding PAG, or were mock transfected (2). The cell lysates were analyzed by SDS PAGE and anti-PAG Western blotting. The blot was restained by
antiserum to b subunits of heterotrimeric G proteins (loading control), and both films were overlaid.1596 The Adaptor Protein PAG Binds Csk and Regulates T Cell Activation
(Fig. 2 C). However, a region of 20 mostly hydrophobic aa
and devoid of charged aa extends from residues 17–36 and
likely corresponds to an a-helical transmembrane domain,
indicating that PAG is a type III transmembrane protein
with an extracellular portion of 16 aa. The transmembrane
domain of PAG is directly followed by a putative palmitoy-
lation site (CSSC; see below). Immediately downstream of
the palmitoylation motif is a sequence of six aa enriched in
basic residues (two arginines and two lysines). The pre-
dicted 397-aa cytoplasmic domain contains a total of 10 ty-
rosines, 9 of which are within potential consensus se-
quences for phosphorylation by Src family PTK (YxxV/L/
I). Among the tyrosine-based signaling motifs, three can be
distinguished (YxxL/V/I(x)nYxxL/V/I) that show some
similarity to ITAMs, although the values of n are larger (14,
14, and 26 residues, respectively) than in typical ITAMs
(Fig. 2 C). In addition to the tyrosine-based signaling mo-
tifs, the cytoplasmic domain contains multiple sites for
phosphorylation by casein kinase 2 and/or protein kinase C
(12 serine and 10 threonine residues). Furthermore, two
proline-rich sequences can be distinguished (positions 131–
138 and 257–263) that may potentially bind to SH3 do-
mains (46). All these motifs, except for the tyrosine residue
corresponding to Y341, are also completely conserved in
mouse PAG (Fig. 2 C). The overall acidic character of
PAG (predicted isoelectric point 4.4) and further modifica-
tion by phosphorylation might result in anomalous binding
of SDS and thus retarded migration on SDS-PAGE, lead-
ing to an apparent molecular mass of 70–85 kD. The struc-
ture of PAG allows it to be designated as a novel trans-
membrane adaptor protein (47, 48).
Previous reports and the data shown above indicated that
in vitro–labeled pp80 migrates at 80–85 kD in SDS-PAGE.
However, the data depicted in Fig. 2 D suggested that in
nonstimulated Jurkat T cells, PAG only runs at about 68–
70 kD. The apparent discrepancy between the molecular
weight of the in vitro–phosphorylated PAG (Fig. 3) versus
its migration when prepared from lysates of nonstimulated
cells suggested that the electrophoretic mobility of PAG is
influenced by its level of tyrosine phosphorylation. Indeed,
the electrophoretic mobility of PAG strongly decreased af-
ter pervanadate treatment of Jurkat cells and corresponded
to the previously observed apparent molecular mass of 85
kD (Fig. 4 A). This demonstrates that in unstimulated Jur-
kat T cells, a submaximally phosphorylated 68-kD form of
PAG predominates that shifts to 80–85 kD upon pervana-
date treatment.
To determine which PTKs may phosphorylate PAG in
vivo, COS cells were cotransfected with cDNAs encoding
FLAG-tagged PAG and various PTKs. As shown in Fig. 4
B, PAG serves as a substrate for Lck and Fyn but not for
ZAP70 and/or Syk. In Jurkat T cells, tyrosine phosphory-
lation of PAG was absent in the Lck-negative Jurkat mu-
tant J.CaM1.6 but was normal or even enhanced in the
ZAP70/Syk-negative mutant P116 (Fig. 4 C), indicating
that Lck might be primarily responsible for PAG phosphor-
ylation in T cells. However, when wild-type Jurkat T cells
(or Raji cells, not shown) were briefly treated with the Src
family PTK–specific inhibitor PP1, the constitutive ty-
rosine phosphorylation of PAG was lost (Fig. 4 D). This
strongly suggests that the phosphorylation status of PAG is
controlled by balanced activities of Src kinases (likely Lck)
and an as yet unidentified tyrosine phosphatase(s).
Tissue and Subcellular Distribution of PAG.  Northern
blot analysis was performed to investigate the pattern of
PAG mRNA expression in human tissues. Fig. 5 A dem-
onstrates that mRNA coding for PAG is expressed in al-
most all tissues examined, the highest level being observed
in the immune system as well as in the lung, heart, and pla-
centa. Interestingly, several bands hybridized with the PAG
cDNA probe. This might indicate the existence of alterna-
tively spliced forms of PAG or PAG-related genes. How-
ever, we did not yet obtain convincing evidence for the
existence of PAG variants on the protein level (not
shown).
Expression of PAG within hematopoietic cells was fur-
ther examined by intracellular immunostaining of perme-
abilized peripheral blood leukocytes. These experiments
Figure 3. PAG is identical to pp80. (A) GEM-associated phosphoproteins were obtained from Raji cells by CD59 immunoprecipitation followed by
in vitro kinase assay (IVK). Phosphorylated proteins were then subjected to reprecipitation using anti-PAG or control (Ctr) mAbs, and were analyzed by
SDS-PAGE followed by autoradiography. (B) Phosphoproteins obtained by immunoprecipitation and in vitro kinase assay of a Fyn immunoprecipitate
prepared from peripheral blood T cells (left) were reprecipitated using a polyclonal mouse antiserum to PAG (center) or a polyclonal rabbit antiserum to
SKAP55 (right), and were analyzed by two-dimensional electrophoresis followed by autoradiography. (C) Laurylmaltoside lysates of peripheral blood a/b T
cells were subjected to preclearing by anti-PAG or control (Ctr) immunosorbents, followed by SDS-PAGE and analysis by anti–P-Tyr (top) or anti-PAG
(bottom) Western blotting. L, untreated lysate.1597 Brdi ka et al. c ˘
revealed strong expression of PAG in lymphocytes and
monocytes and weak expression in neutrophils (Fig. 5 B).
In vitro kinase assay and Western blot analysis indicated
that PAG is also expressed in platelets (not shown).
The subcellular localization of PAG was analyzed by im-
munofluorescence in fixed and permeabilized Raji cells.
Confocal laser scan microscopy demonstrated that PAG
predominantly localizes to the plasma membrane (Fig. 6
A); similar results were observed in Jurkat cells (not
shown). To further analyze in which membrane compart-
ment PAG is localized, Jurkat cells were lysed in Brij58 de-
tergent and subjected to sucrose gradient ultracentrifuga-
tion. As shown in Fig. 6 B, nearly all PAG was present in
buoyant, detergent-resistant GEMs; when cells were solu-
bilized in laurylmaltoside (which effectively dissolves
GEMs), all PAG was detected exclusively in the dense frac-
tions of the gradient (Fig. 6 B). Thus, the major portion of
PAG is localized in the plasma membrane, namely in the
subcompartment corresponding to GEMs.
The cytoplasmic domain of PAG contains a potential
palmitoylation site (CSSC) directly adjacent to the trans-
membrane domain. To determine whether PAG is palmi-
toylated in vivo, Raji B cells were biosynthetically labeled
with  3[H]palmitate, lysed in laurylmaltoside-containing
buffer, and subjected to anti-PAG immunoprecipitation.
As shown in Fig. 6 C, PAG is expressed as a palmitoylated
polypeptide. Identical results were obtained in Jurkat T
cells (not shown), although the radioactive signal was much
weaker than in Raji cells (obviously because Jurkat cells ex-
press much lower amounts of PAG).
PAG Forms a Complex with Csk, which is Functionally Rel-
evant to TCR/CD3 Signaling. The presence of multiple
tyrosine-based motifs suggested that PAG may associate
with SH2 domain–containing cytoplasmic signaling pro-
teins. Indeed, in vitro pull-down assays performed on ly-
sates of pervanadate-treated Jurkat T cells revealed that
phosphorylated PAG strongly binds to the recombinant
SH2 domains of Lck, Fyn, Lyn, Csk, Shc, Vav, GAP, and
PI3K as well as the tandem SH2 domains of ZAP70 and
Syk, whereas it only weakly binds to the SH2 domains of
growth factor receptor binding protein 2 (Grb2), SLP-76,
SH2 domain–containing protein tyrosine phosphatase
(SHP)-1, and SHP-2 (Fig. 7 A).
Based on these results, primary PAG immunoprecipitates
obtained from lysates of unstimulated or pervanadate-
treated hematopoietic cells were analyzed for the presence
Figure 4. Posttranslational modifications of PAG. (A) Lysates of pervanadate-treated (1) or untreated (2) Jurkat cells were analyzed by anti-PAG
Western blotting. (B) COS cells were transiently transfected with the depicted cDNA constructs. Lysates corresponding to 10% of the transfectants were
analyzed by P-Tyr Western blotting (top left). The blot was stripped, and expression of the individual constructs was assessed using FLAG (FLAG-PAG
and FLAG-Syk), Lck, Fyn, and MYC (MYC-ZAP70) Abs, respectively (right). The remaining 90% of the lysates were subjected to anti-FLAG immuno-
precipitation and analyzed by P-Tyr Western blotting (bottom left). Arrowheads indicate the positions of phosphorylated PAG. (C) Anti-PAG (left) and
anti–P-Tyr (right) Western blots of total cell lysates of wild-type Jurkat cells, the Lck-negative mutant J.CaM1.6, and the ZAP70/Syk-negative mutant
P116. (D) Lysates of Jurkat cells treated for 1 min with 10 mM inhibitor of Src family PTKs PP1 (left) or untreated controls (Ctr; right) were analyzed by
anti–P-Tyr blot. The blots were stripped and reincubated with mAb to PAG (bottom).
Figure 5. Tissue distribution of PAG. (A)
Multiple-tissue Northern blot analysis. Posi-
tions of size markers (kb) are shown on the
left. (B) Peripheral blood leukocytes were
permeabilized, stained by mAbs to PAG and
irrelevant negative control (Ctr) followed
by fluorescein-labeled goat anti–mouse IgG,
and analyzed by cytofluorometry. The re-
sults are shown as contour plots (x-axis: in-
tensity of fluorescence in logarithmic scale;
y-axis: side scatter). Different leukocyte
populations are marked: N, neutrophils; M,
monocytes; L, lymphocytes.1598 The Adaptor Protein PAG Binds Csk and Regulates T Cell Activation
of the above cytoplasmic signaling molecules. Small
amounts of Fyn (but not Lck; not shown) were found in
PAG immunoprecipitates prepared from unstimulated pe-
ripheral blood T cells (Fig. 7 B) but not Jurkat or Raji cells
(not shown). Moreover, Fyn and PAG also associated with
each other when coexpressed in COS cells (Fig. 7 E).
However, the interaction between Fyn and PAG seems to
be independent from the tyrosine phosphorylation status of
PAG, as it was not altered after PP1 treatment of the resting
T cells (which caused a strong decrease of PAG tyrosine
phosphorylation; Fig. 7B).
Besides Fyn, the only other candidate molecule repro-
ducibly found to associate with PAG in a variety of cells
(resting T cells, Raji, and Jurkat cells) was the PTK Csk
(Fig. 7 C). Analysis of PAG immunoprecipitates prepared
from transfected COS cells indicated that the interaction
between PAG and Csk requires tyrosine phosphorylation
of PAG by Src kinases (Fig. 7 D). Moreover, PP1-medi-
ated dephosphorylation of PAG in peripheral blood T cells
resulted in a significant loss of the PAG-associated Csk (Fig.
7 B). Finally, expression of PAG molecules in which the
ten cytoplasmic tyrosine residues were individually mutated
to phenylalanine further revealed that the association be-
tween PAG and Csk is to a large extent mediated via the
tyrosine residue Y317 (Fig. 7 E). In contrast, under the same
experimental conditions, Fyn bound to all of the PAG ty-
rosine mutants investigated. This further confirms that the
PAG–Fyn interaction is probably phosphotyrosine inde-
pendent. Taken together, these data indicate that after
phosphorylation by Src family PTKs, PAG recruits Csk to
Figure 6. Subcellular localization of PAG. (A) Raji cells were perme-
abilized and immunostained using PAG mAb MEM-250 (left) followed by
secondary Cy2-labeled anti–mouse IgG (green fluorescence). Nuclei are
visualized by propidium iodide (red fluorescence). In the negative control
(right), PAG mAb was omitted. (B) Lysates of Jurkat cells solubilized in
1% Brij58 or laurylmaltoside (LM) were subjected to sucrose gradient ul-
tracentrifugation, and the fractions (numbered 1–8 from top to bottom)
were analyzed by anti-PAG or anti-LAT Western blotting as indicated.
LAT was used as a well-established control marker of GEMs. S, sediment.
(C) Raji cells were biosynthetically labeled with [3H]palmitate solubilized
in laurylamltoside-containing buffer, and PAG or control (Ctr) immuno-
precipitates were analyzed by SDS-PAGE followed by fluorography.
Figure 7. Fyn and and Csk associate with
PAG. (A) In vitro pull-down assay. Lysates
of untreated (–) or pervanadate (PV)-treated
(1) Jurkat cells were subjected to precipita-
tion using the depicted recombinant GST–
SH2 domain fusion proteins. Subsequently,
anti-PAG or anti-TRIM Western blotting
was performed. (B) Resting peripheral
blood T cells (3 3 107) were left untreated
or were treated with the Src family kinase
inhibitor PP1 (10 mM) for 2 min. Subse-
quently, PAG immunoprecipitates obtained
from laurylmaltoside lysates were subjected
to sequential anti–P-Tyr, anti-Fyn, and
anti-Csk immunoblotting. (C) Untreated Raji, Jurkat, or peripheral blood a/b T cells were solubilized by 1% laurylmaltoside followed by PAG or con-
trol immunoprecipitation and Csk Western blotting. L, original lysates. (D) The blots shown in Fig. 4 B (corresponding to both total lysates [bottom] and
anti-FLAG immunoprecipitates [middle]) were stripped and incubated with a polyclonal antiserum directed against Csk. (E) COS cells (expressing endog-
enous Csk) were transfected with cDNA constructs encoding tyrosine mutants of FLAG-PAG and the PTK Fyn. Anti-FLAG immunoprecipitates were
analyzed by Western blotting for the presence of Csk and Fyn. The numbers at the top identify the Tyr residues mutated to Phe. The expression levels of
Fyn and Csk in total lysates were determined in parallel (bottom strips). None of the investigated PAG mutants showed any gross alterations of the overall
level of tyrosine phosphorylation (not shown).1599 Brdi ka et al. c ˘
Figure 8. PAG is involved in regulation of T cell responses. (A) COS
cells were transfected with the depicted cDNAs. 40 h later, anti-CD25
(Tac) or anti-FLAG (FLAG-PAG) immunoprecipitates (IP) were pre-
pared and subjected to anti–P-Tyr, anti-z, or anti-Csk Western blotting
(top). In parallel, total lysates were analyzed by anti-PAG and anti-Fyn
Western blotting (bottom). (B) Right: COS cells were transfected with
the indicated cDNA constructs followed by lysis in 1% laurylamaltoside,
Fyn immunoprecipitation, in vitro kinase assay, SDS-PAGE, and autoradi-
ography. The expression levels of Fyn in total lysates were determined in
parallel. Left: corresponding densitometric analysis. (C) Jurkat T cells were
transfected with cDNA constructs coding for Fyn, PAG, and FLAG–SLP-
76, respectively, and reporter constructs coding for a triplicated NF-AT
binding site of the human IL-2 promotor and for Renilla luciferase. 16 h
after transfection, 7 3 104 cells per well were stimulated for additional 6 h
using anti-TCR mAb C305, a combination of C305 and CD28 mAb, or
PMA (1029 M) and ionomycin (1 mg/ml). Subsequently, cells were lysed
and luciferase activity was determined. Values represent means of quadru-
plicates. Right: anti-PAG, FLAG (SLP-76), Fyn, and mitogen-activated
protein kinase (MAPK) Western blotting analysis of the transfectants.
Note that overexpression of PAG alone also inhibited TCR- and TCR
plus CD28–mediated induction of NF-AT activity, although to a lesser
extent (z40%; not shown). This might be due to incomplete tyrosine
phosphorylation of PAG in the cells not overexpressing Fyn.
the plasma membrane via a mechanism involving Y317 and
independent from an association between PAG and Fyn.
Csk downregulates the activity of Src kinases via phos-
phorylation of negative regulatory tyrosine residues located
at the COOH termini of the kinases. To investigate
whether membrane targeting of Csk by PAG would lead to
altered substrate phosphorylation by Src family kinases,
COS cells (which express endogenous Csk; Fig. 7 D) were
transiently transfected with cDNA constructs encoding a
chimeric z molecule composed of the extracellular domain
of CD25 (Tac) fused to the transmembrane and cytoplasmic
domains of TCR z chain (Tac/z/z), the Src family PTK
Fyn, and FLAG-tagged PAG. Cell lysates were subjected to
CD25 immunoprecipitation followed by anti–P-Tyr West-
ern blotting. As shown in Fig. 8 A, when coexpressed with
Fyn alone, the Tac/z/z chimera readily became tyrosine
phosphorylated. However, when PAG was coexpressed
with Fyn and Tac/z/z, the level of tyrosine phosphory-
lation of the Tac/z/z chimera markedly decreased, and
this was accompanied by a strong recruitment of endog-
enously expressed Csk to PAG. Similarly, expression of
Csk and PAG resulted in impaired Fyn kinase activity as
judged from an experiment in which Fyn autophosphor-
ylation was assessed by in vitro kinase assays of Fyn im-
munoprecipitates prepared from COS cells transfected
with PAG and Csk cDNAs (Fig. 8 B). These experiments
indicate a negative regulatory role of PAG in T cell activa-
tion based on its ability to recruit Csk to the plasma mem-
brane, followed by downregulation of Src family kinase(s)
activity and inhibition of tyrosine phosphorylation of sub-
strates such as z. In agreement with a negative regulatory
role of PAG during T cell activation was the finding that
PAG, when transiently overexpressed in Jurkat cells,
downregulated TCR-mediated activation of NF-AT (Fig.
8 C), whereas overexpression of the cytoplasmic adaptor
protein SLP-76 upregulated the response as reported previ-
ously (49).
To assess whether binding of Csk to PAG occurs after T
cell activation (which would indicate that the PAG–Csk
complex serves to downregulate Src family kinase activity
after T cell activation) or whether it rather precedes T cell
activation (which would indicate that this complex serves
to downregulate Src kinase activity in the absence of exter-
nal stimuli), we examined the phosphorylation status of
PAG and its association with Csk in nontransformed hu-
man T lymphocytes. To this end, PAG immunoprecipi-
tates were prepared from resting or anti-CD3 plus anti-
CD28–activated peripheral blood a/b T cells and analyzed
by anti–P-Tyr Western blotting. As shown in Fig. 9 B, the
level of tyrosine phosphorylation of PAG and its association
with Csk markedly decreased after activation, whereas its
association with Fyn remained essentially unchanged. At
the same time, moreover, the tyrosine phosphorylation of
other polypeptides (such as pp38 LAT) strongly increased
(Fig. 9 A). Thus, activation of resting peripheral blood a/b
T lymphocytes via the TCR–CD3 complex results in de-
phosphorylation of PAG and concomitant loss of its associ-
ation with Csk.1600 The Adaptor Protein PAG Binds Csk and Regulates T Cell Activation
Discussion
Most recently, major progress has been made in the under-
standing of the molecular mechanisms underlying transloca-
tion of signaling molecules (e.g., phospholipase C g1, SLP-76,
etc.) from the cytosol to the plasma membrane upon T cell ac-
tivation. Thus, a novel group of transmembrane proteins has
been identified whose cytoplasmic domains contain multiple
tyrosine-based signaling motifs that provide docking sites for
the SH2 domains of cytosolic effector molecules after phos-
phorylation by Src or Syk family PTKs. These molecules have
collectively been termed transmembrane adaptor proteins
(47). Until now, three transmembrane adaptor proteins have
been identified, namely LAT (13), TRIM (38), and SHP2-
interacting transmembrane adaptor protein (44). In this report,
we describe identification, purification, Nano ES MS/MS
sequencing, and molecular cloning of a novel transmem-
brane adaptor protein that we termed PAG.
PAG is ubiquitously expressed (Fig. 5 A). This character-
istic (as well as its phosphorylation status in nonstimulated
cells, described below) distinguishes it from the other trans-
membrane adaptor proteins whose expression seems to be
largely restricted to hematopoietic cells. The wide expres-
sion of PAG indicates that transmembrane adaptor proteins
not only play important signaling functions within the he-
matopoietic system but also in other tissues.
PAG comprises a short 16-aa extracellular domain that
likely lacks an external ligand. The cytoplasmic domain of
PAG contains a dicysteine motif (CSSC) that is located di-
rectly downstream of the transmembrane domain (Fig. 2
C) and could serve as a site for palmitoylation, thus allow-
ing targeting of PAG to the GEMs (15). Indeed, in Jurkat
and Raji cells, PAG is expressed as a constitutively palmi-
toylated polypeptide (Fig. 6 C). However, at present we do
not know which of the two cysteines becomes palmitoy-
lated, whether all PAG molecules become targeted to the
GEMs via palmitoylation, and whether palmitoylation of
PAG is essential for its function.
The cytoplasmic domain of human PAG contains 10 po-
tential sites for tyrosine phosphorylation. Coexpression ex-
periments performed in COS cells and analysis of various
Jurkat variants suggest that the Src family PTK Lck might
be responsible for basal tyrosine phosphorylation of PAG in
T cells (Fig. 4, B and C). 6 of the 10 tyrosines are found
within three signaling motifs exhibiting some similarity to
ITAM sequences, but with longer central stretches of aa
than in typical ITAMs. Consistent with these ITAM-like
sequence motifs, in vitro pull-down assays using recombi-
nant GST–SH2 domains revealed that PAG is capable of
binding the tandem SH2 domains of ZAP70 and Syk (Fig.
7 A). However, we have not as yet observed a direct inter-
action between PAG and these two PTKs (or other tandem
SH2 domain–containing signaling molecules such as SHP-1
or SHP-2), even after pervanadate treatment of cells. These
findings might indicate that unknown signaling molecules
exist whose tandem SH2 domains require different spacing
between the two tyrosines for binding.
The phosphorylation of PAG appears to be a tightly reg-
ulated process, as the Src-specific PTK inhibitor PP1 causes
rapid dephosphorylation of PAG in T cells, which is obvi-
ously due to the unopposed activity of an as yet unidenti-
fied tyrosine phosphatase (Fig. 4 D and Fig. 7 B). We have
excluded the possibility that the tyrosine phosphatase
CD45 is dephosphorylating PAG in vivo, as PAG still be-
comes dephosphorylated in PP1-treated J45.01 Jurkat T
cells that lack expression of CD45 (our unpublished obser-
vations). Identification of this phosphatase might be of ma-
jor importance for future research.
Tyrosine-phosphorylated PAG binds to a remarkable
number of different SH2 domains in vitro (Fig. 7 A). This
is consistent with the idea that several, if not all, of the po-
tential tyrosine residues become phosphorylated in vivo,
and that PAG is capable of binding to a variety of intracel-
lular SH2 domain–containing signaling molecules. How-
ever, the only two proteins that we reproducibly found to
interact with PAG were the PTKs Fyn and Csk (Fig. 7).
A low-stoichiometry interaction between Fyn and PAG
was observed in resting peripheral blood T cells (Fig. 7 B and
Fig. 9 B), and both molecules interacted with each other
when coexpressed in COS cells (Fig. 7 E). However, this in-
teraction is apparently not dependent on tyrosine phosphor-
ylation of PAG (Fig. 7, B and E, and Fig. 9 B), which might
suggest that Fyn interacts with PAG via its SH3 domain. In-
deed, two potential SH3-binding sites are present in PAG.
In contrast to Fyn, the PTK Csk was found to associate
with tyrosine-phosphorylated PAG in all types of cells in-
Figure 9. Decrease of PAG tyrosine phos-
phorylation and Csk association with PAG af-
ter stimulation of T cells. (A) Peripheral blood
a/b T cells were stimulated for 1 min by an
IgM anti-CD3 mAb (1) or were left un-
treated (2), and postnuclear lysates were ana-
lyzed by anti–P-Tyr Western blotting. (B)
Lysates of a/b T cells stimulated (1) or un-
stimulated (2) with a mixture of IgM mAbs
to CD3 and CD28 were subjected to anti-
PAG or control immunoprecipitation fol-
lowed by sequential anti–P-Tyr, Csk, PAG,
and Fyn Western blotting. Left: quantitative
evaluation of the data shown at right.1601 Brdi ka et al. c ˘
vestigated by us. This interaction involves a single tyrosine
of PAG (Y317) and is not mediated via Fyn (Fig. 7 E). To-
gether with the finding that PAG strongly binds to the iso-
lated SH2 domain of Csk in vitro (Fig. 7 A), this suggests
that the interaction between PAG and Csk is mediated di-
rectly via the SH2 domain of Csk and Y317 of PAG. How-
ever, a possibility cannot be ruled out that an as yet unidenti-
fied molecule expressed in COS cells (and in lymphocytes)
mediates the association between PAG and Csk. Potential
candidates might be the tyrosine phosphatases protein ty-
rosine phosphatase (PTP)-PEST or PEST-containing phos-
phatase (PEP), which have been shown to bind to the SH3
domain of Csk (50, 51). However, this possibility is un-
likely, because neither of these phosphatases possess SH2
domains that would allow them to bind PAG in a phos-
photyrosine-dependent manner.
Csk is a ubiquitously expressed major negative regulator
of Src family kinases and phosphorylates a negative regula-
tory tyrosine residue near the COOH terminus of the en-
zymes (52–54). Csk-deficient mice die in utero because of
abnormalities in neuronal development (55, 56), which are
obviously due to uncontrolled activity of Src kinases. In
addition, elimination of Csk in thymocytes results in de-
velopment of CD41 T cells independent from pre-TCR–
mediated signals (57). These data indicate that expression of
Csk is required to maintain homeostasis in several tissues,
including the immune system. Csk per se is not a mem-
brane-associated polypeptide, as it does not possess a mem-
brane-targeting motif (e.g., myristylation or palmitoylation
sites as those present in most Src kinases). Thus, in order to
regulate Src kinase activity, a fraction of Csk has to translo-
cate from the cytosol to the plasma membrane. We pro-
pose here that one such mechanism is based on Csk associ-
ation with PAG. This model would be in agreement with
recent data showing that the SH2 domain of Csk is appar-
ently involved in targeting of Csk to the plasma membrane
and is required for Csk-mediated inhibition of T cell acti-
vation (58).
In resting human T cells (as well as in Jurkat T cells and
in Raji B cells), PAG is expressed as a constitutively ty-
rosine-phosphorylated polypeptide and binds Csk in the
absence of any stimuli (Fig. 7, B and C, and Fig. 9 B).
Moreover, immediately after T cell activation, PAG be-
comes dephosphorylated and releases Csk (Fig. 9 B). To-
gether with our observation that PAG is an integral plasma
membrane protein (Fig. 6 A), these data would be compat-
ible with a model proposing that in resting T cells, the con-
stitutively tyrosine-phosphorylated PAG targets a fraction
of Csk to the plasma membrane and thus brings it into
proximity with its substrates, the Src family kinases. Csk
then can phosphorylate the COOH-terminal negative reg-
ulatory tyrosine residues, resulting in downregulation of
the Src kinases enzymatic activity and, as a consequence,
suppression of signal transduction.
In addition, Csk-associated polypeptides like PEP or
PTP-PEST could simultaneously dephosphorylate addi-
tional key signaling molecules such as ZAP70, the TCR z
chains, and/or the autophosphorylation sites of Src kinases,
as was suggested recently (59). At present, we do not know
whether the PAG-associated Csk is complexed with other
negative regulatory signaling proteins (e.g., PEP or PTP-
PEST), either in T cells or in other cell types. Therefore,
we cannot exclude the possibility that the impaired tyrosine
phosphorylation of the Tac z/z chimera and downregula-
tion of the Fyn kinase activity observed after overexpres-
sion of PAG and Csk in COS cells (Fig. 8) is not due only
to Csk-mediated phosphorylation of the negative regula-
tory tyrosine of Fyn. Nevertheless, our data indicate that
PAG binds Csk (Fig. 7, D and E), and that this results (di-
rectly or indirectly) in downregulation of Fyn tyrosine ki-
nase activity and impaired tyrosine phosphorylation of the
TCR z chain (Fig. 8, A and B).
It is also not yet clear which Src family kinases are regu-
lated by the PAG-associated Csk. In T cells, the two major
candidates are Fyn and Lck. Lck has been implicated as the
major PTK in immunoreceptor-mediated phosphorylation
of ITAMs present in the cytoplasmic domains of the TCR-
associated CD3 complex and the z chains. Our experi-
ments so far did not address directly the question whether
Lck is the target of PAG function in T lymphocytes. How-
ever, overexpression of PAG in Jurkat T cells resulted in an
z50% downregulation of TCR-mediated induction of the
transcriptional activity of NF-AT (Fig. 8 C), which is pre-
sumably mediated mainly via Lck; this might indicate that
PAG at least partially downregulates Lck-mediated signal-
ing pathways in vivo.
Alternatively, PAG might also (or even exclusively) in-
fluence signals mediated via Fyn. A preferential interaction
between Fyn and PAG has been suggested previously (33)
and was also demonstrated in this study. Importantly, Fyn
has recently been implicated in signaling processes induced
by b1 integrins in T lymphocytes. Thus, stimulation of
a4b1 integrins by mAbs or natural ligand leads to rapid ty-
rosine phosphorylation of cytosolic proteins that have re-
cently been reported to be selective substrates of Fyn (e.g.,
SLAP-130/FYB and Src kinase–associated phosphoprotein
homolog; references 60, 61). Overexpression of at least one
of these Fyn-specific substrates (SLAP-130) in T cells re-
sults in enhanced migration towards chemokines (61).
Thus, PAG might also be involved in regulating cellular
adhesion and/or migration by altering the enzymatic activ-
ity of Fyn. Further studies in PAG-deficient cell lines and
knockout mice will help to clarify this question.
Nevertheless, our observation that PAG is expressed as a
constitutively tyrosine-phosphorylated molecule that re-
cruits Csk to the plasma membrane could indicate that in
the absence of a stimulus (e.g., antigen), the PAG–Csk
complex increases the signaling threshold required for initi-
ating an immune response and/or helps to keep lympho-
cytes in a resting state. It may be speculated that abnormal
alterations of the phosphorylation status of PAG under cer-
tain pathological conditions (e.g., at sites of local inflamma-
tion) and thus decreased Csk binding may contribute to
hyperactivity of T cells (and other leukocytes as well). This1602 The Adaptor Protein PAG Binds Csk and Regulates T Cell Activation
could be a factor contributing to development of some au-
toimmune disorders, for example. The phosphatase(s) in-
volved in PAG dephosphorylation might thus be an inter-
esting target for pharmacological intervention. In any case,
further analysis of PAG will help to better understand how
external signals become integrated at the intracellular level
to yield an appropriate response of T cells (and also other
cell types) towards externally applied stimuli.
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